Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery
This review elaborates the recent developments in the cationic cyclodextrin-mediated delivery of drugs and nucleic acids. Cationic cyclodextrin-based delivery systems
A forum for researchers, students and applicants in the field of cyclodextrin technology
This review elaborates the recent developments in the cationic cyclodextrin-mediated delivery of drugs and nucleic acids. Cationic cyclodextrin-based delivery systems
Cyclodextrins (CDs) have traditionally been recognized as excipients that enhance solubility and stability of drugs. However, growing evidence shows that
Here a new βCD-based nucleic acid delivery platform is proposed that surmounts the former archetype in its capacity to encode
Gene therapy can be an efficient method to treat genetic diseases, including cancer. However, the lack of biocompatible gene delivery
A supramolecular system was developed for codelivery of doxorubicin (Dox) and p53 gene based on a β-CD-containing star-shaped cationic polymer.
Nucleic acid delivery by viral and non-viral methods has been a cornerstone for the contemporary gene therapy aimed at correcting
This Special Issue aims to showcase cutting-edge research, advancements, and applications of cyclodextrin-based delivery systems in the context of gene
Cyclodextrins have been widely employed for drug delivery systems (DDSs) in which drugs are selectively delivered to a target site
Professor Makoto Komiyama (born in 1947) is a world-famous nucleic acid chemist who is known for using artificial approaches to
Special Issue: Supramolecular Systems for Gene and Drug Delivery (Volume II) has been anounced in the journal Pharmaceutics which has just